| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5944391 | Atherosclerosis | 2015 | 36 Pages |
Abstract
Statin therapy significantly reduces circulating ET-1 concentrations, regardless of treatment duration or dose of statins. This effect of statins may be influenced by statin lipophilicity. There is a need to establish whether lowering ET-1 levels has a beneficial effect on CV events.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Amirhossein Sahebkar, Kazuhiko Kotani, Corina Serban, Sorin Ursoniu, Dimitri P. Mikhailidis, Steven R. Jones, Kausik K. Ray, Michael J. Blaha, Jacek Rysz, Peter P. Toth, Paul Muntner, Gregory Y.H. Lip, Maciej Banach,